List of Awards
Science Classification: Grants and fellowships can have their funding split across several science classifications and financial years. The list below identifies how the funding is divided for this award.
Grant Reference: NE/W003449/2
Title: Soil survival and re-emergence: the continued threat of plague
Total value: £39,645
| ENRIs | FY | Value |
|---|
| Environmental Risks and Hazards | 2022 | £3,050 |
| Environmental Risks and Hazards | 2023 | £6,100 |
| Environmental Risks and Hazards | 2024 | £6,100 |
| Environmental Risks and Hazards | 2025 | £4,575 |
| Global Change | 2022 | £3,050 |
| Global Change | 2023 | £6,100 |
| Global Change | 2024 | £6,100 |
| Global Change | 2025 | £4,575 |
| Science Area | FY | Value |
|---|
| Terrestrial | 2022 | £6,099 |
| Terrestrial | 2023 | £12,199 |
| Terrestrial | 2024 | £12,199 |
| Terrestrial | 2025 | £9,149 |
| Science Topic | FY | Value |
|---|
| Animal pathogens | 2022 | £0 |
| Animal pathogens | 2023 | £0 |
| Animal pathogens | 2024 | £0 |
| Animal pathogens | 2025 | £0 |
| Biofilms | 2022 | £0 |
| Biofilms | 2023 | £0 |
| Biofilms | 2024 | £0 |
| Biofilms | 2025 | £0 |
| Community Ecology | 2022 | £1,708 |
| Community Ecology | 2023 | £3,416 |
| Community Ecology | 2024 | £3,416 |
| Community Ecology | 2025 | £2,562 |
| Comparative genomics | 2022 | £0 |
| Comparative genomics | 2023 | £0 |
| Comparative genomics | 2024 | £0 |
| Comparative genomics | 2025 | £0 |
| Ecosystem function | 2022 | £0 |
| Ecosystem function | 2023 | £0 |
| Ecosystem function | 2024 | £0 |
| Ecosystem function | 2025 | £0 |
| Environmental Microbiology | 2022 | £1,525 |
| Environmental Microbiology | 2023 | £3,050 |
| Environmental Microbiology | 2024 | £3,050 |
| Environmental Microbiology | 2025 | £2,287 |
| Environmental stressors | 2022 | £0 |
| Environmental stressors | 2023 | £0 |
| Environmental stressors | 2024 | £0 |
| Environmental stressors | 2025 | £0 |
| Gene expression | 2022 | £0 |
| Gene expression | 2023 | £0 |
| Gene expression | 2024 | £0 |
| Gene expression | 2025 | £0 |
| Genome sequencing | 2022 | £0 |
| Genome sequencing | 2023 | £0 |
| Genome sequencing | 2024 | £0 |
| Genome sequencing | 2025 | £0 |
| Genomics | 2022 | £1,342 |
| Genomics | 2023 | £2,684 |
| Genomics | 2024 | £2,684 |
| Genomics | 2025 | £2,013 |
| Gram negative | 2022 | £0 |
| Gram negative | 2023 | £0 |
| Gram negative | 2024 | £0 |
| Gram negative | 2025 | £0 |
| Habitat fragmentation | 2022 | £0 |
| Habitat fragmentation | 2023 | £0 |
| Habitat fragmentation | 2024 | £0 |
| Habitat fragmentation | 2025 | £0 |
| Human pathogens | 2022 | £0 |
| Human pathogens | 2023 | £0 |
| Human pathogens | 2024 | £0 |
| Human pathogens | 2025 | £0 |
| Infectious disease | 2022 | £0 |
| Infectious disease | 2023 | £0 |
| Infectious disease | 2024 | £0 |
| Infectious disease | 2025 | £0 |
| Land use | 2022 | £0 |
| Land use | 2023 | £0 |
| Land use | 2024 | £0 |
| Land use | 2025 | £0 |
| Metagenomics | 2022 | £0 |
| Metagenomics | 2023 | £0 |
| Metagenomics | 2024 | £0 |
| Metagenomics | 2025 | £0 |
| Microbial biodiversity | 2022 | £0 |
| Microbial biodiversity | 2023 | £0 |
| Microbial biodiversity | 2024 | £0 |
| Microbial biodiversity | 2025 | £0 |
| Microbial communities | 2022 | £0 |
| Microbial communities | 2023 | £0 |
| Microbial communities | 2024 | £0 |
| Microbial communities | 2025 | £0 |
| Microbial virulence | 2022 | £0 |
| Microbial virulence | 2023 | £0 |
| Microbial virulence | 2024 | £0 |
| Microbial virulence | 2025 | £0 |
| Microbiology | 2022 | £1,525 |
| Microbiology | 2023 | £3,050 |
| Microbiology | 2024 | £3,050 |
| Microbiology | 2025 | £2,287 |
| Sequencing | 2022 | £0 |
| Sequencing | 2023 | £0 |
| Sequencing | 2024 | £0 |
| Sequencing | 2025 | £0 |
| Sequencing technologies | 2022 | £0 |
| Sequencing technologies | 2023 | £0 |
| Sequencing technologies | 2024 | £0 |
| Sequencing technologies | 2025 | £0 |
| Soil microbes | 2022 | £0 |
| Soil microbes | 2023 | £0 |
| Soil microbes | 2024 | £0 |
| Soil microbes | 2025 | £0 |
If you need further help, please read the user guide.